Ambu gets recommendation from FDA, analyst doubts effect

The FDA recommendation that single-use bronchoscopes are used at US hospitals will have little effect, as US lung specialists gave the same advice over a year ago, says Niels Granholm-Leth, Head of Equity Research at Carnegie.

Photo: Ambu / PR

On Friday, the US Food and Drug Administration (FDA) recommended that doctors at US hospitals use single-use bronchoscopes instead of reusable scopes – one year after the American Lung Association gave the same advice.

Many bronchologists are therefore already using single-use scopes rather than reusable scopes, explains Niels Granholm-Leth, Head of Equity Research at Carnegie.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs